BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23294858)

  • 1. Construction and immunogenicity of recombinant porcine circovirus-like particles displaying somatostatin.
    Li W; Wang X; Bai J; Ma T; Li Z; Li Y; Jiang P
    Vet Microbiol; 2013 Apr; 163(1-2):23-32. PubMed ID: 23294858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli.
    Wu PC; Chen TY; Chi JN; Chien MS; Huang C
    J Biotechnol; 2016 Feb; 220():78-85. PubMed ID: 26795354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and immunoprotection of porcine circovirus type 2 (PCV2) Cap protein displayed by Lactococcus lactis.
    Li PC; Qiao XW; Zheng QS; Hou JB
    Vaccine; 2016 Jan; 34(5):696-702. PubMed ID: 26372858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
    Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
    Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Immune Responses to the PCV2 Replicase-Capsid and Capsid Virus-Like Particle Vaccines in Mice.
    Jung BK; Kim HR; Lee YH; Jang H; Chang KS
    J Microbiol Biotechnol; 2019 Mar; 29(3):482-488. PubMed ID: 30609882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2.
    Wang X; Jiang P; Li Y; Jiang W; Dong X
    Vet Microbiol; 2007 Apr; 121(3-4):215-24. PubMed ID: 17215092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of immunogenic recombinant virus-like particles of porcine circovirus type 2 expressed in silkworm pupae.
    Masuda A; Lee JM; Miyata T; Sato T; Hayashi S; Hino M; Morokuma D; Karasaki N; Mon H; Kusakabe T
    J Gen Virol; 2018 Jul; 99(7):917-926. PubMed ID: 29851377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.
    Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C
    Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2.
    Ju C; Fan H; Tan Y; Liu Z; Xi X; Cao S; Wu B; Chen H
    Vet Microbiol; 2005 Aug; 109(3-4):179-90. PubMed ID: 16006077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and immunogenicity of a recombinant pseudorabies virus expressing cap protein of porcine circovirus type 2.
    Song Y; Jin M; Zhang S; Xu X; Xiao S; Cao S; Chen H
    Vet Microbiol; 2007 Jan; 119(2-4):97-104. PubMed ID: 17005335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of the immunogenicity of a porcine circovirus type 2 DNA vaccine by a recombinant plasmid coexpressing capsid protein and porcine interleukin-6 in mice.
    Guo XQ; Wang LQ; Qiao H; Yang XW; Yang MF; Chen HY
    Microbiol Immunol; 2015 Mar; 59(3):174-80. PubMed ID: 25664504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions.
    Martelli P; Ferrari L; Morganti M; De Angelis E; Bonilauri P; Guazzetti S; Caleffi A; Borghetti P
    Vet Microbiol; 2011 May; 149(3-4):339-51. PubMed ID: 21216540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient application of a baculovirus-silkworm larvae expression system for obtaining porcine circovirus type 2 virus-like particles for a vaccine.
    He Q; Cao Z; Wang P; Lu Q; Zheng H; Sun J
    Arch Virol; 2020 Oct; 165(10):2301-2309. PubMed ID: 32757056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses of piglets immunized by a recombinant plasmid containing porcine circovirus type 2 and porcine interleukin-18 genes.
    Chen GL; Fu PF; Wang LQ; Li XS; Chen HY
    Viral Immunol; 2014 Dec; 27(10):521-8. PubMed ID: 25268976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
    Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
    Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and immunogenicity of recombinant swinepox virus expressing capsid protein of PCV2.
    Lin HX; Ma Z; Fan HJ; Lu CP
    Vaccine; 2012 Sep; 30(44):6307-13. PubMed ID: 22884664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B.
    Hu G; Wang N; Yu W; Wang Z; Zou Y; Zhang Y; Wang A; Deng Z; Yang Y
    Vaccine; 2016 Apr; 34(16):1896-903. PubMed ID: 26930366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective humoral immunity in guinea pigs induced by PCV2 virus-like particles displaying the B cell linear epitope (
    Wang N; Zhang S; Wang D; Li F; Liang L; Li X; Zou Y; Zhan Y; Chen G; Yu W; Deng Z; Tu D; Cui S
    Vet Microbiol; 2019 Aug; 235():86-92. PubMed ID: 31282383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of a truncated form of flagellin (TFlg) into porcine circovirus type 2 virus-like particles enhances immune responses in mice.
    Liu X; Liu Y; Zhang Y; Zhang F; Du E
    BMC Vet Res; 2020 Feb; 16(1):45. PubMed ID: 32028949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized production of full-length PCV2d virus-like particles in Escherichia coli: A cost-effective and high-yield approach for potential vaccine antigen development.
    Zhang C; He F; Li N; Du W; Wen J; Wu X; Shi J; Li C; Liu C; Xu S; Han H; Hrabchenko N; Han X; Li J
    Microb Pathog; 2024 May; 190():106630. PubMed ID: 38556102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.